close
Add to watchlist
Antares Pharma Inc (AIS) Healthcare, Medical Equipment & Supplies
Antares Pharma, Inc. operates as a specialty drug delivery/pharmaceutical company. Its drug delivery platforms include Advanced Transdermal Delivery gels, disposable pressure assisted auto injection systems, reusable needle-free injection systems, disposable pen injection systems, and oral disintegrating tablets. The company's transdermal systems consist of semisolid dosage forms, which deliver medication and minimize gastrointestinal impact, as well as the initial liver metabolism effect of orally ingested drugs. Its injection device platform offers reusable needle-free injectors, which deliver precise medication doses through pressurized liquid penetration of the skin without a needle; disposable pressure assisted auto injectors that provide subcutaneous injections with minimal discomfort and safety of a shielded needle; and disposable pen injectors, which are needle-based devices designed to deliver multiple injections from multi-dose drug cartridges. In addition, the company's oral disintegrating tablets are designed to help patients experiencing difficulty in swallowing pills, tablets, or capsules. Antares Pharma sells its products through pharmaceutical and medical device companies primarily in the United States and Europe. It has collaborative arrangements and license agreements with BioSante Pharmaceuticals, Inc.; Jazz Pharmaceuticals; Population Council; Ferring Pharmaceuticals BV; Teva Pharmaceutical Industries, Ltd.; Eli Lilly and Company; JCR Pharmaceuticals Co., Ltd.; and Solvay Pharmaceuticals BV. The company was formerly known as Medi-Ject Corporation and changed its name to Antares Pharma, Inc. in January 2001. Antares Pharma, Inc. was founded in 1979 and is headquartered in Ewing, New Jersey.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 2.80 |
| Volume | 958667 |
| Volume Avg | (mio) 1.39 |
| 52 Week High | 3.00 |
| 52 Week Low | 1.51 |
| PE | N/A |
| PE (group average) | 39 |
| EPS Year | -0.06 |
| EPS change Q/Q | 0% |
| EPS change Q/Q Yr ago | 0% |
| EPS change Q/Q next Q est | 100% |
| EPS change Y/Y | -50% |
| REV change Q/Q | 9.09% |
| REV change Q/Q Yr ago | 5.88% |
| EPS next Q est | 0.00 |
| EPS next Y est | 0.19 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |